Citigroup’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$371K Buy
20,169
+19,546
+3,137% +$224K ﹤0.01% 3712
2025
Q4
$7.39K Sell
623
-175
-22% -$2.23K ﹤0.01% 5140
2025
Q3
$9.49K Buy
+798
New +$10.6K ﹤0.01% 5041
2024
Q2
Sell
-1,377
Closed -$413K 5663
2024
Q1
$413K Buy
1,377
+1,162
+540% +$347K ﹤0.01% 3679
2023
Q4
$50.8K Buy
+215
New +$33.4K ﹤0.01% 4511
2021
Q2
Sell
-31
Closed -$9K 6239
2021
Q1
$9K Sell
31
-44
-59% -$15.8K ﹤0.01% 5691
2020
Q4
$28K Buy
75
+23
+44% +$8.06K ﹤0.01% 6439
2020
Q3
$16K Sell
52
-28
-35% -$10.7K ﹤0.01% 6327
2020
Q2
$30K Sell
80
-44
-35% -$12.5K ﹤0.01% 6319
2020
Q1
$28K Buy
124
+12
+11% +$4.59K ﹤0.01% 6454
2019
Q4
$59K Sell
112
-12
-10% -$6.5K ﹤0.01% 6174
2019
Q3
$53K Sell
124
-340
-73% -$219K ﹤0.01% 6088
2019
Q2
$553K Buy
464
+347
+297% +$415K ﹤0.01% 4318
2019
Q1
$146K Sell
117
-1,031
-90% -$1.18M ﹤0.01% 5395
2018
Q4
$1.09M Buy
1,148
+358
+45% +$431K ﹤0.01% 3306
2018
Q3
$1.14M Buy
790
+196
+33% +$296K ﹤0.01% 3349
2018
Q2
$958K Sell
594
-70
-11% -$120K ﹤0.01% 3408
2018
Q1
$1.08M Buy
664
+653
+5,936% +$1.36M ﹤0.01% 3172
2017
Q4
$18K Buy
+11
New +$14.5K ﹤0.01% 6772
2016
Q4
Sell
-10
Closed -$6.24K 7234
2016
Q3
$7K Hold
10
﹤0.01% 6660
2016
Q2
$8K Buy
+10
New +$6.89K ﹤0.01% 6630
2015
Q4
Sell
-20
Closed -$11K 7664
2015
Q3
$11K Hold
20
﹤0.01% 6373
2015
Q2
$16K Sell
20
-15
-43% -$12.4K ﹤0.01% 6212
2015
Q1
$29K Buy
35
+34
+3,400% +$26.4K ﹤0.01% 5856
2014
Q4
$1K Sell
1
-1
-50% -$783 ﹤0.01% 6964
2014
Q3
$1K Buy
+2
New +$1.62K ﹤0.01% 6905

Other funds holding CBIO